GREENWICH BIOSCIENCES
Greenwich Biosciences' vision is to make a positive difference in the lives of patients through the development of a portfolio of cannabinoid prescription medicines in a wide range of therapeutic indications. Their strategy is to build on their world leading position in the field of cannabinoid science and in the research, development and commercialization of cannabinoid molecules as novel prescription pharmaceutical therapeutic candidates. Epidiolex is Greenwich’s lead cannabinoid produ... ct candidate and is a proprietary oral solution of pure plant-derived cannabidiol, or CBD. Greenwich’s Epidiolex development is initially concentrating on severe, orphan, early-onset, treatment-resistant epilepsy syndromes including Dravet syndrome, Lennox-Gastaut syndrome (LGS), Tuberous Sclerosis Complex (TSC) and Infantile Spasms (IS).
GREENWICH BIOSCIENCES
Industry:
Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.greenwichbiosciences.com
Total Employee:
251+
Status:
Active
Contact:
760-795-2200
Technology used in webpage:
SPF Microsoft Exchange Online Amazon IPv6 Pound Sterling Amazon S3 CDN Microsoft DMARC Japanese Yen MailChimp SPF
Current Employees Featured
Founder
Official Site Inspections
http://www.greenwichbiosciences.com
- Host name: ec2-52-88-89-3.us-west-2.compute.amazonaws.com
- IP address: 52.88.89.3
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Greenwich Biosciences"
Greenwich Biosciences - Crunchbase Company Profile & Funding
Greenwich Biosciences' vision is to make a positive difference in the lives of patients through the development of a portfolio of cannabinoid prescription medicines in a wide range of …See details»
Greenwich LifeSciences, Inc. (GLSI) | GP2
GLSI-100 is a first-of-its-kind therapy that combines GP2, a HER2/neu-derived peptide, with GM-CSF. With 1 in 8 U.S. women developing invasive breast …See details»
Corporate Governance | Greenwich LifeSciences, Inc.
Snehal S. Patel Chief Executive Officer. Over 30 years of experience in executive management, corporate development, operations, and investment banking in …See details»
Greenwich Biosciences - LinkedIn
Greenwich Biosciences | 14,126 followers on LinkedIn. Greenwich Biosciences is now part of Jazz Pharmaceuticals. Follow us at …See details»
Transforming Together: What Our Recent ... - Jazz Pharmaceuticals
Today is an exciting and transformative day for Jazz Pharmaceuticals as we complete the acquisition of GW Pharmaceuticals and its U.S. subsidiary, Greenwich Biosciences, a world …See details»
Greenwich Biosciences - Craft
Greenwich Biosciences is a biopharmaceutical company that develops cannabinoid prescription medicines. It offers EPIDIOLEX (cannabidiol), a prescription formulation of highly purified, …See details»
Greenwich Biosciences, Inc. - CAGE.report
Greenwich Biosciences, Inc. Trade Name ("Doing Business As ..."): DUNS Number: 080113357 Parent DUNS Number: 221420669 Address, line 1: 5750 Fleet St Ste 200 ... Organization, …See details»
Greenwich Biosciences - Overview, News & Similar companies
Greenwich Biosciences Inc is a company that operates in the Pharmaceuticals industry. It employs 11-20 people and has $1M-$5M of revenue. The compa ny is headquartered in …See details»
Greenwich Biosciences, Inc. Company Profile - Dun & Bradstreet
Greenwich Biosciences, Inc. Get a D&B Hoovers Free Trial. Overview Company Description:? Industry: Duns Support Record, nonclassifiable establishment. Printer Friendly View Address: …See details»
Greenwich Biosciences Inc - Company Profile and News
Greenwich Biosciences, Inc. was founded in 2013. The company's line of business includes the manufacturing, fabricating, and processing of drugs in pharmaceutical preparations for human …See details»
Greenwich Biosciences - VentureRadar
Greenwich Biosciences develops cannabinoid prescription medicines and other plant-based pharmaceuticals. NCBiotech Company Directory. Associated sectors: Cannabis-related; Small …See details»
Company Information | Greenwich LifeSciences, Inc. (GLSI) | GP2
Company Greenwich LifeSciences, Inc. 3992 Bluebonnet Drive Building 14 Stafford, TX 77477 T: 832-819-3232See details»
Greenwich Biosciences: Revenue, Worth, Valuation & Competitors …
About Greenwich Biosciences. Greenwich Biosciences is a Pharmaceuticals related company founded in 2013 and based in Carlsbad with an estimated revenue of $14.7M, and 73 …See details»
About | Greenwich LifeSciences, Inc. (GLSI) | GP2
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a clinical-stage public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide …See details»
Greenwich Biosciences Information - RocketReach
The SIC codes for Greenwich Biosciences are [283, 28]. Top Greenwich Biosciences Employees Bob Broadus Director State Government Affairs, Consultant at Greenwich Biosciences New …See details»
GreenwichBiosciences – Walk to End Epilepsy
Anchor Link. At Greenwich Biosciences, we are dedicated to offering innovative solutions that go beyond medicine. Our mission is to transform the lives of children, adults, and families who …See details»
Investors & Media | Greenwich LifeSciences, Inc. (GLSI) | GP2
Apr 3, 2025 Company Profile. Business Description: Greenwich LifeSciences (the “Company”) is a clinical-stage biopharmaceutical company focused on the development of GP2, an …See details»
Greenwich Biosciences Revenue, Growth & Competitor Profile
Mar 10, 2025 Greenwich Biosciences's annual revenues are $100 - $500 million (see exact revenue data) What industry is the company in? Greenwich Biosciences is classified as …See details»
Greenwich Biosciences Company Overview, Contact Details
Greenwich Biosciences 's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing. How many employees does Greenwich …See details»
Leadership | Greenwich LifeSciences, Inc. (GLSI) | GP2
Dr. Thompson has over 30 years of experience in pharmaceutical and device product development. She is a co-founder, clinical advisor, and former Chief Operating Officer of …See details»